226 related articles for article (PubMed ID: 31345376)
1. Role of chemotherapy in 5000 patients with head and neck cancer treated by curative surgery: A subgroup analysis of the meta-analysis of chemotherapy in head and neck cancer.
Dauzier E; Lacas B; Blanchard P; Le QT; Simon C; Wolf G; Janot F; Horiuchi M; Tobias JS; Moon J; Simes J; Deshmane V; Mazeron JJ; Mehta S; Zaktonik B; Tamura M; Moyal E; Licitra L; Fortpied C; Haffty BG; Ghi MG; Gregoire V; Harris J; Bourhis J; Aupérin A; Pignon JP;
Oral Oncol; 2019 Aug; 95():106-114. PubMed ID: 31345376
[TBL] [Abstract][Full Text] [Related]
2. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group.
Lacas B; Carmel A; Landais C; Wong SJ; Licitra L; Tobias JS; Burtness B; Ghi MG; Cohen EEW; Grau C; Wolf G; Hitt R; Corvò R; Budach V; Kumar S; Laskar SG; Mazeron JJ; Zhong LP; Dobrowsky W; Ghadjar P; Fallai C; Zakotnik B; Sharma A; Bensadoun RJ; Ruo Redda MG; Racadot S; Fountzilas G; Brizel D; Rovea P; Argiris A; Nagy ZT; Lee JW; Fortpied C; Harris J; Bourhis J; Aupérin A; Blanchard P; Pignon JP;
Radiother Oncol; 2021 Mar; 156():281-293. PubMed ID: 33515668
[TBL] [Abstract][Full Text] [Related]
3. Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): A meta-analysis of randomized trials.
Budach W; Bölke E; Kammers K; Gerber PA; Orth K; Gripp S; Matuschek C
Radiother Oncol; 2016 Feb; 118(2):238-43. PubMed ID: 26589131
[TBL] [Abstract][Full Text] [Related]
4. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.
Pignon JP; Bourhis J; Domenge C; Designé L
Lancet; 2000 Mar; 355(9208):949-55. PubMed ID: 10768432
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis.
Petit C; Lacas B; Pignon JP; Le QT; Grégoire V; Grau C; Hackshaw A; Zackrisson B; Parmar MKB; Lee JW; Ghi MG; Sanguineti G; Temam S; Cheugoua-Zanetsie M; O'Sullivan B; Posner MR; Vokes EE; Cruz Hernandez JJ; Szutkowski Z; Lartigau E; Budach V; Suwiński R; Poulsen M; Kumar S; Ghosh Laskar S; Mazeron JJ; Jeremic B; Simes J; Zhong LP; Overgaard J; Fortpied C; Torres-Saavedra P; Bourhis J; Aupérin A; Blanchard P;
Lancet Oncol; 2021 May; 22(5):727-736. PubMed ID: 33862002
[TBL] [Abstract][Full Text] [Related]
6. Locally advanced squamous cell carcinoma of the head and neck: A systematic review and Bayesian network meta-analysis of the currently available treatment options.
Iocca O; Farcomeni A; Di Rocco A; Di Maio P; Golusinski P; Pardiñas López S; Savo A; Pellini R; Spriano G
Oral Oncol; 2018 May; 80():40-51. PubMed ID: 29706187
[TBL] [Abstract][Full Text] [Related]
7. A Network Meta-Analysis of the Systemic Therapies in Unresectable Head and Neck Squamous Cell Carcinoma.
Yuan J; Shi K; Chen G; Xu W; Qiu L; Fei Y; Zhu Y; Wu M; Li Y; Sun X; Cao Y; Zhou S
Cancer Control; 2024; 31():10732748241255535. PubMed ID: 38773761
[TBL] [Abstract][Full Text] [Related]
8. Impact of locoregional irradiation in patients with upfront metastatic head and neck squamous cell carcinoma.
Rambeau A; Bastit V; Thureau S; Thariat J; Moldovan C; Roge M; Babin E; Gery B; Di Fiore F; Florescu C; Clatot F
Oral Oncol; 2019 Jun; 93():46-51. PubMed ID: 31109695
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant chemotherapy with S-1 after curative chemoradiotherapy in patients with locoregionally advanced squamous cell carcinoma of the head and neck: Reanalysis of the ACTS-HNC study.
Kubota A; Nakatani E; Tsukahara K; Hasegawa Y; Takemura H; Terada T; Taguchi T; Nagahara K; Nakatani H; Yoshino K; Higaki Y; Iwae S; Beppu T; Hanamure Y; Tomita K; Kohno N; Kawabata K; Teramukai S; Fujii M;
PLoS One; 2018; 13(6):e0198391. PubMed ID: 29883463
[TBL] [Abstract][Full Text] [Related]
10. Intratumor heterogeneity could inform the use and type of postoperative adjuvant therapy in patients with head and neck squamous cell carcinoma.
Mroz EA; Patel KB; Rocco JW
Cancer; 2020 Jan; 126(9):1895-1904. PubMed ID: 32083741
[TBL] [Abstract][Full Text] [Related]
11. Concurrent cisplatin or cetuximab with radiotherapy in patients with locally advanced head and neck squamous cell carcinoma: A meta-analysis.
Tang WH; Sun W; Long GX
Medicine (Baltimore); 2020 Sep; 99(36):e21785. PubMed ID: 32899005
[TBL] [Abstract][Full Text] [Related]
12. Surrogate endpoints for overall survival in locally advanced head and neck cancer: meta-analyses of individual patient data.
Michiels S; Le Maître A; Buyse M; Burzykowski T; Maillard E; Bogaerts J; Vermorken JB; Budach W; Pajak TF; Ang KK; Bourhis J; Pignon JP;
Lancet Oncol; 2009 Apr; 10(4):341-50. PubMed ID: 19246242
[TBL] [Abstract][Full Text] [Related]
13. Induction chemotherapy decreases the rate of distant metastasis in patients with head and neck squamous cell carcinoma but does not improve survival or locoregional control: a meta-analysis.
Ma J; Liu Y; Huang XL; Zhang ZY; Myers JN; Neskey DM; Zhong LP
Oral Oncol; 2012 Nov; 48(11):1076-84. PubMed ID: 22800881
[TBL] [Abstract][Full Text] [Related]
14. The Effect of Induction Chemotherapy Using Docetaxel, Cisplatin, and Fluorouracil on Survival in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Meta-Analysis.
Kim R; Hahn S; Shin J; Ock CY; Kim M; Keam B; Kim TM; Kim DW; Heo DS
Cancer Res Treat; 2016 Jul; 48(3):907-16. PubMed ID: 26582394
[TBL] [Abstract][Full Text] [Related]
15. Role of adjuvant chemoradiotherapy in T4N0 stage IV head and neck cancer: A National Cancer Database analysis.
Kirke DN; Qureshi MM; Kamran SC; Ezzat W; Jalisi S; Salama A; Everett PC; Truong MT
Head Neck; 2018 Jun; 40(6):1174-1184. PubMed ID: 29417687
[TBL] [Abstract][Full Text] [Related]
16. Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age.
Chen MM; Colevas AD; Megwalu U; Divi V
Oral Oncol; 2018 Sep; 84():71-75. PubMed ID: 30115479
[TBL] [Abstract][Full Text] [Related]
17. Phase 1 study of EGFR-antisense DNA, cetuximab, and radiotherapy in head and neck cancer with preclinical correlatives.
Bauman JE; Duvvuri U; Thomas S; Gooding WE; Clump DA; Karlovits B; Wehbe A; Miller FR; Kim S; Sen M; Heron DE; Grandis JR; Argiris A
Cancer; 2018 Oct; 124(19):3881-3889. PubMed ID: 30291796
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients.
Pignon JP; le Maître A; Maillard E; Bourhis J;
Radiother Oncol; 2009 Jul; 92(1):4-14. PubMed ID: 19446902
[TBL] [Abstract][Full Text] [Related]
19. Predictive classifier for intensive treatment of head and neck cancer.
Zakeri K; Rotolo F; Lacas B; Vitzthum LK; Le QT; Gregoire V; Overgaard J; Hackshaw A; Zackrisson B; Parmar MKB; Burtness BA; Ghi MG; Sanguineti G; O'Sullivan B; Fortpied C; Bourhis J; Shen H; Harris J; Michiels S; Pignon JP; Mell LK;
Cancer; 2020 Dec; 126(24):5263-5273. PubMed ID: 33017867
[TBL] [Abstract][Full Text] [Related]
20. Phase 2 trial of neoadjuvant chemotherapy and transoral endoscopic surgery with risk-adapted adjuvant therapy for squamous cell carcinoma of the head and neck.
Weiss JM; Grilley-Olson JE; Deal AM; Zevallos JP; Chera BS; Paul J; Knowles MF; Usenko D; Weissler MC; Patel S; Hayes DN; Hackman T
Cancer; 2018 Jul; 124(14):2986-2992. PubMed ID: 29741773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
